By Kathryn Brenzel ( April 8, 2013, 3:14 PM EDT) -- German drugmaker Merz Pharma Group said Monday it has abandoned its bid for Obagi Medical Products Inc. after Valeant Pharmaceuticals International Inc. upped its offer to about $418 million, ending what amounted to a weeklong bidding war for the California cosmetics company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.